Tag Archives: Malaria Vaccine
Berlin: The University of Tubingen researchers in collaboration with the biotech company Sanaria Inc have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.
London (IANS): The first malaria vaccine candidate to reach phase-3 of clinical testing was found to partially protect children against the disease up to four years after vaccination and may be available by as early as October this year, scientists reported.
London: GlaxoSmithKline (GSK) on Thursday announced that it has submitted a regulatory application to the European Medicines Agency (EMA) for its malaria vaccine candidate, RTS,S.
Washington: A form of malaria common in India, Southeast Asia and South America attacks human red blood cells by clamping down on the cells with a pair of proteins, new research at Washington University School of Medicine in St Louis has revealed.
Kolkata: Amid expectations of the world’s first malaria vaccine by 2015, a leading British expert on Saturday stressed on collective efforts to prevent the disease and hoped Indian pharma companies would come out with an affordable product. He also hoped cricketers and film stars would join the campaign to prevent malaria.
Kolkata: As countries like India and Africa — hotbeds for malaria — await the world’s first vaccine against the disease, a leading expert said on Saturday the results of clinical trials were “modestly encouraging”, but nations should be cautious.
London: Results from a large-scale Phase III trial, presented recently at the MIM (Multilateral Initiative on Malaria) Pan-African Malaria Conference in Durban, South Africa, show that the malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 months after vaccination, according to a statement issued by GlaxoSmithKline (GSK).
New Delhi: Australian Prime Minister Julia Gillard on Friday welcomed the scientific communities of India and Australia working together to develop a vaccine to fight the scourge of malaria.
Sydney: Researchers at the Burnet Institute have made a major breakthrough in the quest for a vaccine against malaria, which causes up to one million deaths each year.
London: A new candidate malaria vaccine with the potential to neutralise all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford. The results of this new vaccine independently confirm the utility of a key discovery reported last month from scientists at the Wellcome Trust Sanger Institute who had identified this target within the parasite as a potential ‘Achilles’ heel’ that could hold significant promise for vaccine development.